Report cover image

Industrial Electrification Market, By Source, By Technology, By End-Use Industry, By Country, and By Region – Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

Publisher AnalystView Market Insights
Published Sep 04, 2025
Length 260 Pages
SKU # ANVM20791180

Description

REPORT HIGHLIGHT

Industrial Electrification Market size was valued at US$ 39,925.01 Million in 2024, expanding at a CAGR of 6.60% from 2025 to 2032.
Electrification is one of the six key processes of energy decarbonization that converts waste energy into useful energy sources that can then be used for a variety of applications. The energy transition refers to reducing the use of fossil fuels for energy production and shifting to cleaner energy sources such as renewable energy.
Industrial Electrification Market- Market Dynamics

Increasing emphasis on energy efficiency and sustainability.
The growing emphasis on energy efficiency and sustainability is a critical driver of industrial electrification adoption around the world. Industries are increasingly looking for ways to reduce energy consumption and greenhouse gas emissions in order to comply with strict environmental regulations and achieve corporate social responsibility goals. Electrification provides a more efficient and flexible alternative to traditional fossil-fuel-based systems by allowing for greater control over energy consumption and seamless integration of renewable energy sources. General Electric and Siemens, for example, have played critical roles in promoting industrial electrification as a means of improving energy efficiency and sustainability. For instance, GE's Grid Solutions division focuses on electrification and the integration of renewable energy sources like solar and wind into industrial operations. This helps industries reduce their reliance on fossil fuels and reduce carbon emissions.
Industrial Electrification Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.60% over the forecast period (2025-2032)
Based on Technology segmentation, Over the course of the study, the electric resistance heating market is anticipated to expand quickly.
Based on End-Use Industry segmentation, the manufacturing sector will dominate the worldwide industrial electrification market in 2025.
On the basis of region, Asia Pacific was the leading revenue generator in 2024
Industrial Electrification Market- Segmentation Analysis:

The Global Industrial Electrification Market is segmented on the basis of Source, Technology, End-Use Industry, and Region.
Six categories are used to categorize the market according to technology: Heat Pumps, Energy Storage, Electric Arc Heating, Electric Boilers, Electric Resistance Heating and Others. The electric resistance heating segment is expected to grow at a rapid pace during the study period. The technological features of precise temperature control and rapid heating enable its use in a variety of industrial processes. Electric resistance heating systems integrate into existing industrial setups with minimal modifications, making them desirable to implement. Electric resistance heating adoption is increasing as industries seek to reduce carbon emissions while utilizing renewable energy sources and improving efficiency. Furthermore, new breakthroughs in electric resistance heating are increasing its industrial importance.
The market is divided into eight categories according to end-use industry: Manufacturing, Pulp and Paper, Mining, Chemicals, Construction, Steel and Cement, Oil and Gas, Others. In 2025, the manufacturing segment will lead the global industrial electrification market, as businesses prioritize sustainable operations and efficient production processes. The increasing use of electric machinery with industrial heat solutions has resulted in a reduction in fossil fuel dependence while also supporting global decarbonization efforts. The adoption of electrified manufacturing technologies skyrocketed as industrial energy transition policies strengthened market leadership. Furthermore, official government documents demonstrated how industrial electrification helped to reduce emissions in specific facilities while maintaining industrial sector control.
Industrial Electrification Market- Geographical Insights

Asia Pacific will dominate the industrial electrification market in 2025 due to rapid industrial development and urbanization. The region grew as a result of government policies that promoted renewable energy integration and the conversion of industrial processes to electrical operation. The need for sustainable practices prompted industrial operators to install electric machinery, which improved energy efficiency and reduced carbon emissions. The World Health Organization confirmed that solar photovoltaic systems combined with battery storage systems evolved into cost-effective, adaptable solutions that sped up the power-up process throughout the region.
North America has a significant presence in the global industrial electrification market, due to governments investing heavily in clean industry sectors and implementing favorable policies. The implementation of greenhouse gas emission reduction goals and energy independence initiatives has accelerated industrial electrification in a variety of business sectors. North America has excellent potential for industrial electrification advancement due to its commitment to sustainable practices and technological advancements. The Inflation Reduction Act of 2022 provided significant financial incentives for businesses to electrify their operations, reinforcing regional strength.
Industrial Electrification Market- Competitive Landscape:

The industrial electrification market is fiercely competitive, with global players like ABB, Continental AG, AISIN CORPORATION, Bonfiglioli Transmissions Private Limited, and BorgWarner Inc. dominating the landscape with comprehensive electrification, automation, and energy management offerings. These companies are working to modernize industrial infrastructure by integrating smart grids, electrifying machinery, installing EV charging stations, and distributing energy more efficiently. The global push toward decarbonization, digital transformation, and demand for resilient energy systems in industries such as manufacturing, mining, and logistics have all contributed to intense competition. Strategic partnerships, acquisitions, and investments in AI-enabled platforms and IoT-based energy monitoring are defining the competitive advantage. While North America and Europe lead in advanced industrial frameworks and regulatory support, Asia-Pacific is emerging as a key growth region as a result of rapid industrialization and clean energy transitions.

Recent Developments:

In April 2024, Siemens Smart Infrastructure has launched Electrification X, a new suite of applications in their SaaS and IoT portfolio. This offering is intended to assist renewable generators, transmission and distribution system operators (TSOs), industries, and infrastructure customers in improving productivity, reliability, asset utilization, energy efficiency, and sustainable innovation.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INDUSTRIAL ELECTRIFICATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

ABB
Continental AG
AISIN CORPORATION
Bonfiglioli Transmissions Private Limited
BorgWarner Inc.
DENSO CORPORATION
General Electric
Johnson Electric Holdings Limited
Bharat Bijlee Limited
Kirloskar Electric Company
Others

GLOBAL INDUSTRIAL ELECTRIFICATION MARKET, BY SOURCE- MARKET ANALYSIS, 2019 - 2032

Fossil Fuel-based
Renewable Energy
Solar Energy
Wind Energy
Hydropower
Geothermal
Nuclear Power
Nuclear Fission
Nuclear Fusion
Others

GLOBAL INDUSTRIAL ELECTRIFICATION MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

Heat Pumps
Energy Storage
Electric Arc Heating
Electric Boilers
Electric Resistance Heating
Others

GLOBAL INDUSTRIAL ELECTRIFICATION MARKET, BY END-USE INDUSTRY- MARKET ANALYSIS, 2019 - 2032

Manufacturing
Pulp and Paper
Mining
Chemicals
Construction
Steel and Cement
Oil and Gas
Others

GLOBAL INDUSTRIAL ELECTRIFICATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

Table of Contents

260 Pages
1. Frontotemporal Dementia Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Frontotemporal Dementia Market Snippet by Drug Class
2.1.2. Frontotemporal Dementia Market Snippet by Disease Indication
2.1.3. Frontotemporal Dementia Market Snippet by Distribution Channel
2.1.4. Frontotemporal Dementia Market Snippet by Country
2.1.5. Frontotemporal Dementia Market Snippet by Region
2.2. Competitive Insights
3. Frontotemporal Dementia Key Market Trends
3.1. Frontotemporal Dementia Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Frontotemporal Dementia Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Frontotemporal Dementia Market Opportunities
3.4. Frontotemporal Dementia Market Future Trends
4. Frontotemporal Dementia Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Frontotemporal Dementia Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Frontotemporal Dementia Market Landscape
6.1. Frontotemporal Dementia Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Frontotemporal Dementia Market – By Drug Class
7.1. Overview
7.1.1. Segment Share Analysis, By Drug Class, 2024 & 2032 (%)
7.1.2. Cognitive Enhancers
7.1.3. Antidepressants
7.1.4. Antipsychotics
7.1.5. CNS Stimulants
7.1.6. Other Drug Classes
8. Frontotemporal Dementia Market – By Disease Indication
8.1. Overview
8.1.1. Segment Share Analysis, By Disease Indication, 2024 & 2032 (%)
8.1.2. Frontotemporal Dementia
8.1.3. Movement Disorders
8.1.4. Primary Progressive Aphasia
9. Frontotemporal Dementia Market – By Distribution Channel
9.1. Overview
9.1.1. Segment Share Analysis, By Distribution Channel, 2024 & 2032 (%)
9.1.2. Hospital Pharmacies
9.1.3. Online Pharmacies
9.1.4. Retail Pharmacies
10. Frontotemporal Dementia Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Frontotemporal Dementia Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Frontotemporal Dementia Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.3.9.5. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Frontotemporal Dementia Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.4.6. APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.4.7.5. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.4.8.5. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Frontotemporal Dementia Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Frontotemporal Dementia Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.6.6. MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Frontotemporal Dementia Industry
11.1. Competitive Benchmarking
11.1.1. Competitive Dashboard
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Transposon Therapeutics
11.2.2. AstraZeneca plc
11.2.3. Alector Inc.
11.2.4. Pfizer Inc.
11.2.5. Denali Therapeutics Inc.
11.2.6. Johnson & Johnson Services Inc.
11.2.7. Prevail Therapeutics
11.2.8. Wave Life Sciences
11.2.9. GlaxoSmithKline plc
11.2.10. TauRx Pharmaceuticals Ltd.
11.2.11. Others
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us